Published in Ophthalmology on June 01, 1999
The neuro-ophthalmology of mitochondrial disease. Surv Ophthalmol (2010) 1.51
Mitochondrial proteomics of the retinal pigment epithelium at progressive stages of age-related macular degeneration. Invest Ophthalmol Vis Sci (2008) 1.31
Spare the rod and spoil the eye. Br J Ophthalmol (2005) 1.28
Autosomal dominant retinitis pigmentosa mutations in inosine 5'-monophosphate dehydrogenase type I disrupt nucleic acid binding. Biochem J (2005) 1.27
Characterisation of the macular dystrophy in patients with the A3243G mitochondrial DNA point mutation with fundus autofluorescence. Br J Ophthalmol (2008) 0.90
Endocrine disorders in mitochondrial disease. Mol Cell Endocrinol (2013) 0.83
Neuromuscular and systemic presentations in adults: diagnoses beyond MERRF and MELAS. Neurotherapeutics (2013) 0.82
Genetic linkage analysis of a novel syndrome comprising North Carolina-like macular dystrophy and progressive sensorineural hearing loss. Br J Ophthalmol (2003) 0.80
The Role of the Transcription Factor Foxo3 in Hearing Maintenance: Informed Speculation on a New Player in the Cochlea. Biomed Res Int (2016) 0.75
Asymmetric severity of diabetic retinopathy in Waardenburg syndrome: response to authors. Clin Ophthalmol (2012) 0.75
Macular dystrophy associated with the mitochondrial DNA A3243G mutation: pericentral pigment deposits or atrophy? Report of two cases and review of the literature. BMC Ophthalmol (2014) 0.75
Pearls & oy-sters: maternally inherited diabetes and deafness presenting with ptosis and macular pattern dystrophy. Neurology (2012) 0.75
Mitochondrial DNA abnormalities in ophthalmological disease. Saudi J Ophthalmol (2011) 0.75
Human iPSC disease modelling reveals functional and structural defects in retinal pigment epithelial cells harbouring the m.3243A > G mitochondrial DNA mutation. Sci Rep (2017) 0.75
Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature (1997) 7.33
A study of the prevalence of eye disease in the elderly in an English community. Trans Ophthalmol Soc U K (1985) 5.91
Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3) Nature (1996) 5.32
Diabetes in identical twins. A study of 200 pairs. Diabetologia (1981) 5.02
Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis. Diabetologia (2010) 4.33
Management of hyperlipidaemia: guidelines of the British Hyperlipidaemia Association. Postgrad Med J (1993) 4.28
Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia (2010) 4.13
The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum Mol Genet (1996) 3.37
A genomewide scan for loci predisposing to type 2 diabetes in a U.K. population (the Diabetes UK Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. Am J Hum Genet (2001) 3.26
A search for type 1 diabetes susceptibility genes in families from the United Kingdom. Nat Genet (1998) 2.85
Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study. Diabet Med (2012) 2.80
Altered globe dimensions of axial myopia as risk factors for penetrating ocular injury during peribulbar anaesthesia. Br J Anaesth (2000) 2.79
Effect of linagliptin monotherapy on glycaemic control and markers of β-cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial. Diabetes Obes Metab (2011) 2.68
Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia (2008) 2.44
A correlation between the relative predisposition of MHC class II alleles to type 1 diabetes and the structure of their proteins. Hum Mol Genet (2001) 2.43
Blindness and partial sight in an elderly population. Br J Ophthalmol (1986) 2.39
Mutations in the human delta homologue, DLL3, cause axial skeletal defects in spondylocostal dysostosis. Nat Genet (2000) 2.28
Mutations in hepatocyte nuclear factor-1beta and their related phenotypes. J Med Genet (2005) 2.24
Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype. Diabetologia (2006) 2.24
Common nonsynonymous substitutions in SLCO1B1 predispose to statin intolerance in routinely treated individuals with type 2 diabetes: a go-DARTS study. Clin Pharmacol Ther (2010) 2.22
Enhanced diabetes care to patients of south Asian ethnic origin (the United Kingdom Asian Diabetes Study): a cluster randomised controlled trial. Lancet (2008) 2.21
Visual evoked responses in children with migraine: a diagnostic test. Lancet (1990) 2.19
Nitric oxide synthase gene polymorphisms and diabetic nephropathy. Diabetologia (2003) 2.18
Anti-Kell in pregnancy. Br J Obstet Gynaecol (1991) 2.14
Common variants in the TCF7L2 gene are strongly associated with type 2 diabetes mellitus in the Indian population. Diabetologia (2006) 2.14
The role of serum lipids in exudative diabetic maculopathy: is there a place for lipid lowering therapy? Eye (Lond) (2002) 2.13
Improved genetic testing for monogenic diabetes using targeted next-generation sequencing. Diabetologia (2013) 2.13
Pain response and follow-up of patients undergoing panretinal laser photocoagulation with reduced exposure times. Eye (Lond) (2007) 2.12
The genetic abnormality in the beta cell determines the response to an oral glucose load. Diabetologia (2002) 1.99
A distant upstream promoter of the HNF-4alpha gene connects the transcription factors involved in maturity-onset diabetes of the young. Hum Mol Genet (2001) 1.98
Parent-offspring trios: a resource to facilitate the identification of type 2 diabetes genes. Diabetes (1999) 1.97
The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes. Diabetologia (2012) 1.89
A novel mutation causing DEND syndrome: a treatable channelopathy of pancreas and brain. Neurology (2007) 1.89
Abnormal nephron development associated with a frameshift mutation in the transcription factor hepatocyte nuclear factor-1 beta. Kidney Int (2000) 1.87
Low plasma C4 concentrations: association with microangiopathy in insulin dependent diabetes. Br Med J (Clin Res Ed) (1984) 1.82
Clinical features, diagnosis and management of maternally inherited diabetes and deafness (MIDD) associated with the 3243A>G mitochondrial point mutation. Diabet Med (2008) 1.82
The high prevalence of unrecognized anaemia in patients with diabetes and chronic kidney disease: a population-based study. Diabet Med (2008) 1.73
Chlorpropamide alcohol flushing and diabetic retinopathy. Lancet (1979) 1.72
Cataract and survival in an elderly nondiabetic population. Arch Ophthalmol (1993) 1.72
Linkage disequilibrium between the human leukocyte antigen class II region of the major histocompatibility complex and Graves' disease: replication using a population case control and family-based study. J Clin Endocrinol Metab (1998) 1.72
Fractured somatotopy in granule cell tactile areas of rat cerebellar hemispheres revealed by micromapping. Brain Behav Evol (1978) 1.71
First UK survey of paediatric type 2 diabetes and MODY. Arch Dis Child (2004) 1.70
Referral rates for diagnostic testing support an incidence of permanent neonatal diabetes in three European countries of at least 1 in 260,000 live births. Diabetologia (2009) 1.70
Serum high molecular weight complex of adiponectin correlates better with glucose tolerance than total serum adiponectin in Indo-Asian males. Diabetologia (2005) 1.69
Islet autoantibodies can discriminate maturity-onset diabetes of the young (MODY) from Type 1 diabetes. Diabet Med (2011) 1.68
FTO gene variants are strongly associated with type 2 diabetes in South Asian Indians. Diabetologia (2008) 1.65
Mutations in the hepatocyte nuclear factor-1beta gene are associated with familial hypoplastic glomerulocystic kidney disease. Am J Hum Genet (2000) 1.64
Identification of susceptibility loci for insulin-dependent diabetes mellitus by trans-racial gene mapping. Nature (1989) 1.64
Medical conditions underlying retinal vein occlusion in patients with glaucoma or ocular hypertension. Br J Ophthalmol (1989) 1.63
Prevalence of symptoms of depression and anxiety in a diabetes clinic population. Diabet Med (2000) 1.61
Hypoglycaemic counter-regulation at normal blood glucose concentrations in patients with well controlled type-2 diabetes. Lancet (2000) 1.61
Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes. J Clin Invest (1999) 1.60
Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12. Diabetes (1996) 1.60
Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4alpha mutations in a large European collection. Diabetologia (2005) 1.60
Simultaneous pulmonary and cerebral oedema, and multiple CNS infarctions as complications of diabetic ketoacidosis: a case report. Diabet Med (2006) 1.60
The HLA-DPB1--associated component of the IDDM1 and its relationship to the major loci HLA-DQB1, -DQA1, and -DRB1. Diabetes (2001) 1.58
A year in a general ophthalmic outpatient department in England. Arch Ophthalmol (1986) 1.58
Maternal diabetes alters birth weight in glucokinase-deficient (MODY2) kindred but has no influence on adult weight, height, insulin secretion or insulin sensitivity. Diabetologia (2000) 1.57
Resistin, central obesity, and type 2 diabetes. Lancet (2002) 1.56
Asian patients attending a diabetic clinic. Br Med J (Clin Res Ed) (1985) 1.55
Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. Diabetologia (2012) 1.55
A genetic diagnosis of HNF1A diabetes alters treatment and improves glycaemic control in the majority of insulin-treated patients. Diabet Med (2009) 1.54
Heritability estimates for beta cell function and features of the insulin resistance syndrome in UK families with an increased susceptibility to type 2 diabetes. Diabetologia (2004) 1.54
SLC2A2 mutations can cause neonatal diabetes, suggesting GLUT2 may have a role in human insulin secretion. Diabetologia (2012) 1.54
Partial and whole gene deletion mutations of the GCK and HNF1A genes in maturity-onset diabetes of the young. Diabetologia (2007) 1.52
Retinal vein occlusion and the prevalence of lipoprotein abnormalities. Br J Ophthalmol (1982) 1.52
Can insulin-treated diabetics be given beta-adrenergic blocking drugs? Br Med J (1980) 1.52
The values history: an innovation in surrogate medical decision-making. Law Med Health Care (1990) 1.50
A male-female bias in type 1 diabetes and linkage to chromosome Xp in MHC HLA-DR3-positive patients. Nat Genet (1998) 1.50
The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabet Med (2013) 1.50
PINK1 (PARK6) associated Parkinson disease in Ireland. Neurology (2004) 1.49
Clinical presentation of 6q24 transient neonatal diabetes mellitus (6q24 TNDM) and genotype-phenotype correlation in an international cohort of patients. Diabetologia (2013) 1.48
beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors. Diabetes (2001) 1.47
A 'fail-safe' screening programme for diabetic retinopathy. J R Coll Physicians Lond (1998) 1.40
Pneumomediastinum in diabetic ketoacidosis. Diabet Med (1989) 1.40
Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus. Eur J Clin Invest (1997) 1.40
Special needs of elderly diabetic patients. BMJ (1993) 1.39
Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease. Neurology (2008) 1.39
Does microvascular disease predict macrovascular events in type 2 diabetes? Atherosclerosis (2011) 1.38
Replication of 13 genome-wide association (GWA)-validated risk variants for type 2 diabetes in Pakistani populations. Diabetologia (2011) 1.37
Superficial siderosis of the central nervous system many years after neurosurgical procedures. J Neurol Neurosurg Psychiatry (2003) 1.37
Hepatocyte nuclear factor-1beta: a new kindred with renal cysts and diabetes and gene expression in normal human development. J Am Soc Nephrol (2001) 1.36
Maturity-onset diabetes of the young: from clinical description to molecular genetic characterization. Best Pract Res Clin Endocrinol Metab (2001) 1.36
Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetes. Diabet Med (2000) 1.34
Urine C-peptide creatinine ratio is an alternative to stimulated serum C-peptide measurement in late-onset, insulin-treated diabetes. Diabet Med (2011) 1.33
A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria. Diabetologia (2000) 1.31
Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction. Ophthalmology (2001) 1.31
Exenatide compared with long-acting insulin to achieve glycaemic control with minimal weight gain in patients with type 2 diabetes: results of the Helping Evaluate Exenatide in patients with diabetes compared with Long-Acting insulin (HEELA) study. Diabetes Obes Metab (2009) 1.31
Insulin VNTR allele-specific effect in type 1 diabetes depends on identity of untransmitted paternal allele. The IMDIAB Group. Nat Genet (1997) 1.31
Mutations in the hepatocyte nuclear factor-1alpha gene are a common cause of maturity-onset diabetes of the young in the U.K. Diabetes (1997) 1.29